Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital
Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital
复制标题
DOI：
10.1136/jnis.2009.000497
复制
发表时间：
2009-12-01
影响因子：
4.8
通讯作者：
Fiorella, D.
中科院分区：
文献类型：
--
作者：
Moskowitz, S. I.;Kelly, M. E.;Fiorella, D.
背景和目的Warcadil和阿司匹林对症状性颅内疾病（WASID）数据的影响结合Wingspan支架系统的商业发布描述了三级护理center.Methods血管内病例日志从2004年4月至2007年7月的神经介入治疗症状性颅内动脉粥样硬化性疾病（ICAD）的频率。计算了颅内神经介入治疗的总数和针对症状性ICAD进行的神经介入治疗（单纯经皮腔内血管成形术（PTA）或支架植入术（PTAS））的数量。结果应用Wingspan系统治疗后，ICAD神经介入治疗的频率从7/354例（2%）增加到56/367例（15.3%），增加了763%（P
Background and Purpose The impact of the Warfarin and Aspirin for Symptomatic Intracranial Disease (WASID) data is described in combination with the commercial release of the Wingspan stenting system on the frequency of neurointervention for the treatment of symptomatic intracranial atherosclerotic disease (ICAD) in a tertiary care center.Methods Endovascular case logs were reviewed from April 2004 to July 2007. The total number of intracranial neurointerventions and the number of neurointerventions (percutaneous transluminal angioplasty alone (PTA) or with stenting (PTAS)) performed for symptomatic ICAD were calculated. The time period evaluated was divided into two equal 19.5-month epochs representing the time periods before and after the availability of the Wingspan system.Results The frequency of neurointerventions for ICAD increased by 763%, from seven of 354 total cases (2%) to 56 of 367 total cases (15.3%) (p